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Introduction

Discussion

Mycobacterium szulgai is a rare nontuberculous mycobacterium (NTM) pathogen reported
in <1% of diseases related to mycobacterium. Its presence is clinically significant and
is mostly found in immunocompromised individuals with an existing and/or underlying
lung disease. Upon diagnosis and pathogen sensitivities, treatment is recommended
with triple therapy over prolonged period of time to prevent complications and further
respiratory deterioration. This type of pathogen mostly forms upper lobe cavitations and
may radiologically and clinically resemble tuberculosis.

Case Report
A 59-year-old Caucasian male with oxygen dependent COPD presented with complaints
of subjective fevers, chills, hemoptysis and fatigue after. He had a similar presentation
one year ago when he was treated for right lobar necrotizing pneumonia with negative
diagnostic work-up. Upon this admission, he was febrile at 101oF with CT chest showing
left upper lobe cavitary pneumonia. Diagnostic work-up showed leukocytosis of 15,000
with negative blood cultures. An acid-fast stain of bronchial washing fluid was positive
and susceptibility testing demonstrated Mycobacterium szulgai. He was promptly started
on triple therapy – Clarithromycin, Rifabutin and Bactrim DS for a 12 month period
with routine blood work to monitor for side effects. Over the duration of treatment, his
symptoms improved and his imaging showed interval improvements due to treatment.

In 2007, the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) published
diagnostic criteria for NTM infection. The guidelines consist of clinical, radiological, and microbiological criteria
as listed = 1) pulmonary symptoms, nodular or cavitary opacities on chest radiograph, or a HRCT scan that
show multifocal bronchiectasis with multiple small nodules, 2) appropriate exclusion of other diagnoses, such as
tuberculosis, and 3) positive culture results from at least two separate expectorated sputum samples.
Mycobacterium szulgai is a slow-growing NTM that presents as an opportunistic pathogen in individuals with
systemic immune suppression or pulmonary disease. It accounts for less than 1% of all non-tuberculous
mycobacterium infections. Pulmonary M. szulgai is often clinically identical to M. tuberculosis with symptoms such
as weight loss, cough, hemoptysis and radiographic evidence of cavitary lesions. The demographic distribution is
commonly in men above the age of 50 with risk factors such as tobacco or alcohol abuse with COPD and/or history
of pulmonary tuberculosis. Diagnosis, as defined by American Thoracic Society – is with pulmonary symptoms,
exclusion of other diseases with a positive culture, specifically from bronchial fluid. Given our patient’s demographic
profile and ultimate diagnosis, it becomes important to keep this pathogen as part of a differential when there is
suspicion for mycobacterial infection and even with detection of small numbers of M. szulgai, susceptibility testing
and treatment should begin promptly given its long-term treatment and possible morbidity.

Diagnosis
•	Grows at 37 in 12-25 days, Niacin (-), Nitrite (+)
•	Only AFB that has different light test based on
temperature
o

		-	Scotochromogen at 37o
		-	Photochromogen at 25o

•	Unique characteristic of this species:
•	No human to human spread, environment is the
source of human infections

Figure 1: Right upper lobe lung cavitary lesion – a
classic hallmark of NTM as presented in this case.
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American Thoracic Society Diagnostic Criteria of Nontuberculous) Mycobacterial Lung Disease
Clinical criteria
1.	Pulmonary symptoms, nodular or cavitary opacities on chest radiograph, or an HRCT scan that
shows multifocal bronchiectasis with multiple small nodules.
and
2.	Appropriate exclusion of other diagnoses.
Microbiological criteria
1.	Positive culture results from at least two separate expectorated sputum samples. (If the results
from the initial sputum samples are nondiagnostic, consider repeat sputum AFB smears and
cultures.)
or
2.	Positive culture results from at least one bronchial wash or lavage.
or
3.	Transbronchial or other lung bipsy with mycobacterial histopathologic features (granulomatous
inflammation or AFB) and positive cultures for NTM or biposy showing mycobacterial
histopathologic features (granulomatous inflammation or AFB) and one or more sputum or
bronchial washings taht are culture positive for NTM.
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